Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Return on Assets (2022 - 2025)

Historic Return on Assets for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to 1.16%.

  • Lucid Diagnostics' Return on Assets rose 4200.0% to 1.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.16%, marking a year-over-year increase of 4200.0%. This contributed to the annual value of 1.57% for FY2024, which is 1900.0% up from last year.
  • Lucid Diagnostics' Return on Assets amounted to 1.16% in Q3 2025, which was up 4200.0% from 1.55% recorded in Q2 2025.
  • In the past 5 years, Lucid Diagnostics' Return on Assets ranged from a high of 1.16% in Q3 2025 and a low of 1.95% during Q1 2025
  • Its 4-year average for Return on Assets is 1.54%, with a median of 1.56% in 2025.
  • Data for Lucid Diagnostics' Return on Assets shows a peak YoY increase of 4200bps (in 2025) and a maximum YoY decrease of -3600bps (in 2025) over the last 5 years.
  • Quarter analysis of 4 years shows Lucid Diagnostics' Return on Assets stood at 1.58% in 2022, then decreased by -10bps to 1.74% in 2023, then increased by 2bps to 1.71% in 2024, then skyrocketed by 32bps to 1.16% in 2025.
  • Its Return on Assets was 1.16% in Q3 2025, compared to 1.55% in Q2 2025 and 1.95% in Q1 2025.